Quantum Media Group, LLC

Quantum Media Group, LLC has been a member of Linktree for 2 years and joined in September 2024. The social media accounts linked to from Quantum Media Group, LLC are: • Instagram • TikTok • YouTube • X Besides social media accounts, quantummediallc has populated their site with: • Driving Innovation in Telecoms: An Interview with David Zoldan, CEO of Launch 3 Telecom - TechBullion • Q&A with Matt Edelman, CEO at Super League | citybiz • Modern Fashion: Aaron Tuchman Of Noble Custom Suits On 5 Things You Need To Lead a Successful Fashion Brand Today | by Authority Magazine Editorial Staff | Authority Magazine | Jan, 2026 | Medium • Peter Goldstein Of Exchange Listing LLC: Five Things I Wish Someone Told Me Before I Became A CEO | by Authority Magazine Editorial Staff | Authority Magazine | Sep, 2025 | Medium • Bitcoin IRA: Helping Americans Retire with Crypto | NYSE Interview with Chris Kline • The summer slide is real. The 30-minute-a-week math hack parents are raving about • AI Biologics: The Overlooked Frontier of Drug Discovery? | Investing.com • Mark Madrid: Fueling Small Business Excellence Through AI, Access & Action | NYSE Interview • Biotech Breakout? How a 2-Week Depression Pill Could Trigger a Market Repricing • The Future is Faster Than You Think: Dr Yun K Tam of SinoVeda • Zedge: Making Phones Personal • Scrip Asks... What Does 2025 Hold For Biopharma? Part 6: Therapeutic Area Advances • The Future of Anxiety Relief • Major Shareholder Doubles Down: Pluri Lands $3.5M Premium Investment as Growth Plans Accelerate • Q&A with Yaky Yanay, President and CEO, Pluri | citybiz • A Transformative Shift in Cancer Care: How One Partnership Is Bringing AI to Healthcare • Scrip Asks... What Does 2025 Hold For Biopharma? Part 4: Artificial Intelligence and Data Science • Here Are Four Small-Cap Stocks in Honor of World Cancer Day • Israel's Pluri secures $6.5M strategic Investment, Enters Cacao market - AgroSpectrum Asia • Pluri Secures $6.5M Investment, Acquires Cacao Company • Lab-Grown Chocolate: Israel's Pluri Acquires Kokomodo, Raises $6.5M • Yaky Yanay: Revolutionizing Biotech with Pluri's Cell-Based Solutions • Pluri CEO & President Yaky Yanay • These Biotechs are Using the Same Treatments for Multiple Neurodegenerative Diseases: Here's Why it Works • Biotechs are Accelerating Drug Discovery by Repurposing Platforms: What This Means for Investors • Artificial Intelligence Makes Possible a Multiomic Approach in Oncology Drug Discovery • Unlocking AI investment opportunities in healthcare • Inhibikase Therapeutics: Targeted Therapies That Can Improve Quality Of Life | Investing.com • Next-gen farming | The Cell Base • Sustainability innovations that made headlines in 2024 - Natura Hoy • How Creative Marketers Use Artificial Intelligence to Deliver a Better Experience • Tech Is Shaping the Future of Food: Here's How Venture Capital is Carrying that Tech Across the Finish Line • Best-Performing Small-Cap Stocks of 2024 | Investing.com • 3 Must-Have Cars For the Traveling Entrepreneur • Under-the-Radar Way to Invest in AI: 6 Health-Care Stocks for Exposure to Artificial Intelligence • These 3 Things Are Going to Change the Business Landscape Forever • Four Things Every Investor Relations Officer Needs to Know About AI • With climate change threatening commodity foods, these technologies are coming to the rescue • New Technology Addresses At-Risk Commodity Ingredients - Food Industry Executive • IPA's Innovative Approach to Antibody Discovery and AI Integration - Top Entrepreneurs Podcast | Enterprise Podcast Network • Malta or Portugal: Navigating Investment Migration Options • C-Suite Perspectives On AI: Dr Jennifer Bath Of ImmunoPrecise Antibodies On Where to Use AI and • Climate Change Is Coming for these Food Staples, So Technology is Taking Farming into the Lab • Commodity Markets at Risk for Destabilization as Tech Takes Farming Into the Lab | Investing.com • Improving Cell Therapy Supply Chains • FORMULATION DEVELOPMENT - Practical & Purposeful: Creating Novel Compounds Via Rediscovery R&D & Cannabinoid Molecules • Simplifying Diabetes with an Implantable CGM – Paul V. Goode, PhD, Glucotrack CEO • New frontier for battery metals: Q&A with Craig Shesky, CFO of The Metals Company By Investing.com • Don't write off cultivated meat just yet, says Ever After Foods: ‘We’re not offering incremental improvements but something truly disruptive’ • No matter who wins the election, experts expect 'a significant number' of rich Americans to flee the country • Greening Your Investments: How to Protect Your Portfolio Against Climate Threats | Investing.com • Jon Green Of Latitude On the Future Of Work • Advancing Cell Therapies in Development Through CDMOs • Pluri, BIRAD bring tumor-fighting MAIT cells to commercial viability • ImmunoPrecise touts potential of rabbit monoclonal antibodies in oncology - Pharmaceutical Technology • Pluri launches manufacturing division as cell therapy pipeline progresses - Pharmaceutical Technology • Harnessing the Power of Data Analytics in Investor Relations • Shaping the Future of Longevity With Yaky Yanay And James “Jim” Roosevelt from Pluri : How Pluri’s Therapies Are Shaping the Future of Aging and Healthcare • Frontiers of Healing: Joel Latham’s Quest to Transform Modern Medicine • How AI Technology Is Revolutionizing Early Breast Cancer Detection and Treatment • Leading the Biotherapeutics Revolution: Interview with Dr. Jennifer Bath, CEO of ImmunoPrecise Antibodies • AgTech: Michal Ogolnik On The New Technologies That Are Revolutionizing Agriculture • Regenerative Medicine is the Future of Healthcare | Pluri CEO, Yaky Yanay, Co-hosted with Juvenescence Chairman, Dr. Greg Bailey • Jon Green Podcast Transcript • Climate change is actually draining our bank accounts. Here's what to do • Future of Metal Production: Craig Shesky and The Metals Company’s Mission • Joel Latham, Incannex Healthcare, on a Promising New Combination Therapy for Obstructive Sleep Apnea • 3D Cell-Expansion Technology Revolutionizing Industries: Interview with Lior Raviv, Chief Technology Officer at Pluri • These Four Biotech Stocks Tap into the Impact-Investing Movement • Ever wondered how deep-sea nodules power EVs? 🌊🔋 • Innovative Strides in Sleep Apnea Treatment: Incannex’s IHL-42X Enters Pivotal Phase 2/3 Trials. • Passport to prosperity: Why high-net-worth individuals need dual citizenship • 4 Psychedelic Stocks to Consider as Clinical Trials Heat up | Investing.com • Off the Shelf Platform: Efrat Kaduri from Pluri Inc. In a Riveting Conversation with PharmaShots • Latitude’s Chris Willis Talks About Real Estate and What to Know About Foreign Citizenship and Residency by Investment • IPA Therapeutics: A HUB of Biotherapeutic Intelligence • Ascent Solar: Solar power solution for scenarios where traditional rigid panels won't work • 3 under-the-radar ways the Inflation Reduction Act has made significant impact (including to your wallet) • Securing Your Future through Investment Migration - Interview with Managing Partner: Jon Green • How to overcome the challenges of mechanical contactors for efficient EV charging • Driving Efficiency and Affordability in Energy with Ideal Power CEO, Dan Brdar • Driving Disruption: Joel Latham Of Incannex Healthcare On The Innovative Approaches They Are Taking… • CDMO Specialization • USA: Jennifer Bath on IPA's AI-Driven Drug Discovery, Solving Data Overload in Pharmaceuticals • Unsung Heroes in the Fight Against Climate Change: 5 Small Caps for Climate Week | investing.com • How NVIDIA Stock Became a Wall Street Darling After Years Under the Radar | Investing.com • How Cannabinoid Biotechs Are Potentially Enhancing Long-Term Stock Performance | Investing.com • Pluri bags $1.4m to advance nuclear radiation therapy • EXCLUSIVE: Seabed Mining Company Execs See Industry Developing Regardless Of UN Authority Vote - TMC Metals (NASDAQ:TMC) • Stirring the pot: Bioreactor breakthroughs | The Cell Base • USA: Pluri's Tech Revolution: Mass Cell Production & Future Solutions • Vehicles of The Future: Jeff Knapp Of Ideal Power On The Leading Edge Technologies That Are Making… • Pluri: Transforming cells into solutions • Is CPAP Technology Becoming Obsolete? New Treatments Offer Hope in Sleep Apnea • The Future of Cell-Based Products with Yaky Yanay, CEO of Pluri • The Technology Behind The Technology: How Ideal Power is Driving EVs Forward - Top Entrepreneurs Podcast | Enterprise Podcast Network • 69% of OSA Patients Willing to Switch to Pill Treatment, Finds Quantum Research-Incannex Survey • Ever After Foods receives $10 million investment • Sleep Apnea Pill: Quantum Research Survey Shows Sleep Apnea Patients Seeking CPAP Alternatives • Why Millennials Still Respond to This Old-School Marketing Tactic • More Drug Does Not Always Lead to More Efficacy: Dr Mark Bleackley on the Progress of the RePOSA Study